Centers for Disease Control and Prevention. Valley Fever (Coccidioidomycosis)  Accessed March 14, 2024.

Davis MR, Nguyen MH, Donnelly MA, Thompson GR 3rd. Tolerability of long-term fluconazole therapy. J Antimicrob Chemother. 2018;74(3):768-771. doi:10.1093/jac/dky501

Hoenigl M, Sprute R, Egger M, et al. The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin. Drugs. 2021;81(15):1703-1729. doi:10.1007/s40265-021-01611-0

Johnson RH, Sharma R, Kuran R, Fong I, Heidari A. Coccidioidomycosis: a review. J Investig Med. 2021 Feb;69(2):316-323. doi: 10.1136/jim-2020-001655

Landman K. The devil lurking in the dust. Vox. April 20, 2023.  Accessed March 14, 2024.

University of Arizona Valley Fever Center for Excellence. Valley Fever(Coccidioidomycosis) A Training Manual for Primary Care Professionals. 2019. Regents for the Valley Fever Center for Excellence. Accessed April 12, 2024.